SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000827871-15-000004
Filing Date
2015-01-20
Accepted
2015-01-20 10:10:06
Documents
3
Period of Report
2015-01-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k.htm 8-K 22574
2 PRESS RELEASE DATED JANUARY 20, 2015 a20150120egrxfyendchangepr.htm EX-99.1 6385
3 EAGLE LOGO a20150120egrxfyendcha_image1.jpg GRAPHIC 85201
  Complete submission text file 0000827871-15-000004.txt   147782
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 15534534
SIC: 2834 Pharmaceutical Preparations